Sunday, April 23, 2017 10:36:02 PM
Looking at Focalin .. The 15mg and 30mg uses to enjoy $200M sales in 2013 before generics kicked in. We know these two made about $600k royalty for IPCI last quarter , 3 years later
Seroquel , all strength enjoyed $1B ..
assuming MNK can be half as successful as PAR launch .. royalty on sales (excluding profit from manufacturing ) should be about $1.5M a quarter, 3 years down the road
Manufacturing profit should be about same as royalty ... leading to $3M a quarter total net .. 3 years firm the road .. profits should be higher initially
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM